Article
FiercePharmaAsia—Daiichi's win-lose week; Astra's China business; Novavax-Fuji
Rating:
0.0
Views:
67
Likes:
1
Library:
1
Daiichi Sankyo won a $1 billion upfront deal with AstraZeneca on an anti-TROP antibody-drug conjugate but lost a pediatric pentavalent vaccine collab with Sanofi. AstraZeneca's China business was hurt by a huge Pulmicort decline. Fujifilm will make Novavax's experimental COVID-19 vaccine. And more.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value